Abstract
The first administration of misonidazole to a patient receiving radiotherapy was performed at Mount Vernon on the 1st November 1974. In the first phase of the work, when large single doses were given to 8 patients, we showed that good serum concentrations could be achieved in man with doses which were fairly well tolerated when given orally. The curve of plasma concentration showed a peak at 1 to 2 hours and then a period of slow-fall called the plateau period extending up to 4 or 5 hours. The concentration then fell away with a half-life of approximately 12 hours. Enhancement of radiation response in skin made artificially hypoxic was demonstrated in all 6 cases studied and concentrations up to 100% of the plasma concentration were found in biopsies of human tumours. An enhancement of tumour response was observed in 3 of 4 patients with multiple deposits of tumour where a comparison could be made of treatment with or without the drug (1,2,3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Dische, A. J. Gray and G. D. Zanelli, Clinical testing of the radiosensitizer Ro 07–0582. II. Radiosensitization of normal and hypoxic skin, Clin. Radiol. 27:159 (1976).
A. J. Gray, S. Dische, G. E. Adams, I. R. Flockhart, and J. L. Foster, Clinical testing of the radiosensitizer Ro 07–0582. I. Dose tolerance, serum and tumour concentration, Clin. Radiol. 27:151 (1976).
R. H. Thomlinson, S. Dische, A. J. Gray, and L. M. Errington, Clinical testing of the radiosensitizer Ro 07–0582. III. Regression and regrowth of tumour, Clin. Radiol. 27:167 (1976).
S. Dische, M. I. Saunders, M. E. Lee, G. E. Adams, and I. R. Flockhart, Clinical testing of the radiosensitizer Ro 07–0582: Experience with multiple doses, Br. J. Cancer 35:567 (1977).
M. I. Saunders, S. Dische, P. Anderson, and I. R. Flockhart, The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum, Br. J. Cancer 37(Suppl.III):268 (1978).
S. Dische, M. I. Saunders, I. R. Flockhart, M. E. Lee and P. Anderson, Misonidazole. A drug for trial in radiotherapy and oncology, Int. J. Radiat. Oncol. Biol. Phys. 5:851 (1979).
S. Dische, M. I. Saunders, and I. R. Flockhart, The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials, Br. J. Cancer 37(Suppl.III):318 (1978).
J. Denekamp, F. J. Fowler and M. C. Joiner, Misonidazole in fractionated radiotherapy: little and often? Br. J. Radiol. (Awaiting publication).
R. Sealy and W. Levin, Clinical experience with misonidazole as a radiation sensitizer and as a radiation sensitizer in conjunction with hyperbaric oxygen or hyperthermia, Cancer Clin. Trials (1980)(Awaiting publication).
N. M. Bleehen, The Cambridge glioma trial misonidazole and radiation therapy with associated pharmacokinetic studies, Cancer Clin. Trials (1980)(Awaiting publication).
H. D. Kögelnik, Clinical experience with misonidazole. High dose fractions versus daily low doses, Cancer Clin. Trials 3:179 (1980).
T. H. Wasserman and T. L. Phillips, Clinical trials of misonidazole in the United States, Cancer Clin. Trials (1980) (Awaiting publication).
J. P. Bataini, Personal communication (1980).
S. Dische, Hyperbaric oxygen. The Medical Research Council trials and their clinical significance, Br. J. Radiol. 51:888 (1978).
T. A. Rich, S. Dische, M. I. Saunders, M. Stratford and A. Minchinton, The influence of necrosis on the concentration of misonidazole in human tumors, Int. J. Radiat. Oncol. Biol. Phys. (Awaiting publication).
S. Dische, M. I. Saunders, P. Anderson, M. E. Lee, J. F. Fowler, M. Stratford and A. Minchinton, A drug for improved radio-sensitization in radiotherapy, Br. J. Cancer (1980) (Awaiting publication).
D. V. Ash, M. R. Smith and R. D. Bugden, The distribution of misonidazole in human tumours and normal tissue, Br. J. Cancer 39:503 (1979).
S. Dische, M. I. Saunders, P. J. Riley, J. Hauck, M. H. Bennett, M. R. L. Stratford and A. I. Minchinton, The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid, Br. J. Cancer (1980) (Submitted for publication).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Dische, S. (1982). Misonidazole and Desmethylmisonidazole in Clinical Radiotherapy. In: Breccia, A., Rimondi, C., Adams, G.E. (eds) Advanced Topics on Radiosensitizers of Hypoxic Cells. NATO Advanced Study Institutes Series, vol 43. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0399-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0399-3_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0401-3
Online ISBN: 978-1-4757-0399-3
eBook Packages: Springer Book Archive